Use of Lactulose Breath Tests to Predict Response to Rifaximin in Irritable Bowel Syndrome With Diarrhea: The Positives and Negatives
Am J Gastroenterol
.
2020 Jun;115(6):955-956.
doi: 10.14309/ajg.0000000000000569.
Authors
Christopher J Black
1
2
,
Alexander C Ford
1
2
Affiliations
1
Leeds Gastroenterology Institute, St. James's University Hospital, Leeds, UK.
2
Leeds Institute of Medical Research at St. James's, University of Leeds, Leeds, UK.
PMID:
32118590
DOI:
10.14309/ajg.0000000000000569
No abstract available
Publication types
Comment
MeSH terms
Breath Tests
Diarrhea
Humans
Irritable Bowel Syndrome*
Lactulose
Rifamycins*
Rifaximin
Substances
Rifamycins
Lactulose
Rifaximin